BioMADE will be investing in state-of-the-art bioindustrial manufacturing infrastructure in Minnesota, following support of up to $100 million from Governor Tim Walz and the Minnesota Legislature in the 2023 legislative session. The forthcoming biomanufacturing infrastructure investments in Minnesota will be the first start in a national network of...

The Minnesota Senate Jobs and Economic Development Committee today held an informational hearing on BioMADE today as part of a discussion on S.F. 2598 , which would empower BioMADE to create a bioindustrial manufacturing innovation and production campus in Minnesota. This first-of-its-kind project would put Minnesota in the center of a 21st century...

The NIIMBL eXperience is an exclusive in-person, all expenses paid immersion program that offers you real-world insight into biopharmaceutical industry careers through hands-on activities and direct interactions with industry professionals. The program targets African American/Black, Latinx, and Native...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded over $200k in funding to launch the 2023 NIIMBL eXperience program in three distinct locations across the United States. Funding recipients include Albany College (ACPHS) in New York, BioKansas in the Kansas/Missouri Region, and Raritan Valley Community...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in collaboration with BioPhorum is pleased to announce that the data and design specification for the NIIMBL BioPhorum Buffer Stock Blending System are now publicly available for open-source use. This new current good manufacturing practices (cGMP) buffer technology...